Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 2,681 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,681 shares of Phreesia stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $27.95, for a total value of $74,933.95. Following the completion of the sale, the chief operating officer now directly owns 769,993 shares of the company’s stock, valued at approximately $21,521,304.35. This represents a 0.35 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $76,450.53.
• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total transaction of $38,758.29.

Phreesia Stock Performance

NYSE:PHR opened at $26.75 on Friday. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The stock has a market cap of $1.55 billion, a P/E ratio of -18.20 and a beta of 0.94. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. The firm has a 50-day moving average of $22.87 and a two-hundred day moving average of $22.62.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same quarter in the prior year, the business posted ($0.58) earnings per share. Phreesia’s revenue for the quarter was up 16.6% on a year-over-year basis. On average, research analysts expect that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Truist Financial increased their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and lifted their target price for the company from $24.00 to $32.00 in a report on Wednesday. KeyCorp upped their price target on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday. Robert W. Baird decreased their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Finally, Citigroup raised their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $31.00.

Institutional Trading of Phreesia

A number of hedge funds and other institutional investors have recently made changes to their positions in PHR. Versor Investments LP acquired a new position in Phreesia during the 3rd quarter worth $694,000. Zacks Investment Management acquired a new position in Phreesia in the third quarter worth about $631,000. Sei Investments Co. increased its holdings in Phreesia by 135.3% in the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after buying an additional 95,058 shares during the last quarter. State Street Corp raised its stake in Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares in the last quarter. Finally, Barclays PLC lifted its holdings in Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock worth $2,163,000 after buying an additional 43,225 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.